Brief: Oramed Subsidiary Oravax Medical Signs Deal For An Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 Vaccines With Tan Thanh Holdings To Commercialize In Southeast Asia

Oramed Pharmaceuticals

29/12/2021 11:05

Dec 29 (Reuters) - Oramed Pharmaceuticals Inc  ORMP.O :
    * ORAMED SUBSIDIARY ORAVAX MEDICAL SIGNS COOPERATION AND
PURCHASE
AGREEMENT FOR AN INITIAL PRE-PURCHASE OF 10 MILLION DOSES OF
ORAL COVID-19 VACCINES WITH TAN THANH HOLDINGS TO COMMERCIALIZE
IN SOUTHEAST ASIA
    * ORAMED - INITIAL PRE-PURCHASE OF 10 MILLION DOSES OF ORAL
VACCINES WITH A POTENTIAL DEAL FOR FURTHER ORDERS WORTH HUNDREDS
OF MILLIONS OF DOLLARS
    * ORAMED - AGREEMENT GRANTS TAN THANH HOLDINGS RIGHT TO SELL
ORAVAX'S ORAL VACCINE IN DEVELOPMENT THROUGHOUT ASSOCIATION OF
SOUTHEAST ASIAN NATIONS

Source text for Eikon:  ID:nPnb6D5Hka 
Further company coverage:  ORMP.O 

 ((Reuters.Briefs@thomsonreuters.com;;))